Translate

Thursday, June 16, 2016

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer Jason S. Coomer

Under the Foreign Corrupt Practices Act and the SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.  By gathering this evidence and going through a lawyer, these whistleblowers can protect their identity through the process and potentially collect large rewards of 10% to 30% of the monetary sanctions including disgorged funds.  In cases where systematic bribery schemes have created large drug company revenues of over $1 billion USD, these rewards can be between $100 million USD and $300 million USD.  For more information on this topic, please go to the following web pages:  Chinese Doctors Are Needed to Expose Drug Bribery Schemes and Expose Drug Company Bribes and Earn Large Rewards.

The Chinese Drug Market Is The Target of Many Multinational Drug Companies  

The Chinese pharmaceutical market is one of the fastest growing drug markets in the world.  To capitalize on this fast growing market several drug companies are offering illegal bribes and other incentives to Chinese doctors in order to increase drug sales in China.  These illegal bribery schemes include paying Chinese doctors and Chinese health officials with gift cards, illegal trips, and slush funds to prescribe specific drugs and influence treatment guidelines.

Some of these bribery schemes are extremely complicated and involve systematic gifts given to doctors through accounting fraud and marketing fraud.  Such marketing schemes are illegal under Chinese law and can be the basis for large SEC Bounty Action Rewards.

China Drug Company Bribe Whistleblower Lawyer Jason Coomer Helping Whistleblowers Report Fraud and Claim Rewards

Jason Coomer, who heads a law firm in Austin, Texas, has a Chinese language website offering assistance to whistleblowers. His office and his co-counsel have received around 50 whistleblower reports from China in the last three years and are now taking eight cases forward to the SEC.

We're talking large multinational corporations with multi-billion dollar contracts each year. The whistleblowers are insiders at the corporations as well as doctors who have witnessed elaborate bribery schemes, he told Reuters in on telephone interview from Texas. He declined to give further details about the cases.
   

Wednesday, June 15, 2016

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards by China Drug Whistleblower Lawyer Jason Coomer

Doctors and other medical professionals are being offered large financial rewards and whistleblower protections to expose drug company bribes, medical device company bribes, and medical supply company bribes.  These whistleblower protections include being able to file a bounty action through an international whistleblower lawyer in order to protect the medical professional's identity.  For more information on exposing illegal bribes and collecting large rewards, please go to the following web page: Chinese Doctors Can Confidentially Expose Drug Company Bribes.

Drug Company Bribes, Medical Device Company Bribes, and Medical Supply Company Bribes in China Can
Be The Basis For Large Bounty Action Rewards

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to
7% to around $880 billion. This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland, and Ukraine. These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicine purchases, and pharmaceutical contracts are lost to corrupt and fraudulent acts. As such, there is an international movement to reward pharmaceutical professionals and health care professionals that expose fraudulent and corrupt practices that cost hundreds of billions of dollars and cost lives. This international movement includes SEC Foreign Corrupt Practices Act Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits which offer whistleblowers large rewards for properly exposing bribes.  Medical providers with first hand knowledge or evidence of large bribes are encouraged to step forward to properly expose these illegal bribes.